Search Login Register
Lovastatin
(Mevacor)
Summary
Description:
A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver.
Also Known As:
Mevacor; 6-Methylcompactin; Lovastatin, (1 alpha(S*))-Isomer; Lovastatin, 1 alpha-Isomer (without R*/S* notation); MK-803; Monacolin K; 6 Methylcompactin; MK 803; MK803; Mevinolin; Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-
Networked: 1199
relevant articles (122 outcomes,
262 trials/studies)
for this Drug
Key Diseases for which Lovastatin is
Relevant
-
Hypercholesterolemia
:
24 outcomes 46 studies in 221 results
-
Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
:
10 outcomes 8 studies in 56 results
-
Nephrotic Syndrome (Syndrome, Nephrotic)
:
8 outcomes 4 studies in 19 results
-
Neoplasms (Cancer)
:
7 outcomes 17 studies in 140 results
-
Hyperlipidemias (Hyperlipidemia)
:
7 outcomes 11 studies in 59 results
Show All >>
Drugs Related to Lovastatin
-
Cholesterol
-
Simvastatin (Zocor)
-
LDL Cholesterol
-
Pravastatin (Pravachol)
-
Lipoproteins (Lipoprotein)
-
Colestipol (Colestid)
-
Gemfibrozil (Lopid)
-
Niacin (Nicotinic Acid)
-
atorvastatin (Lipitor)
-
fluvastatin
Show All >>
Therapies Related to Lovastatin
-
Heart Transplantation (Grafting, Heart)
-
Diet Therapy (Therapy, Diet)
-
Combination Drug Therapy (Combination Chemotherapy)
-
Continuous Ambulatory Peritoneal Dialysis (CAPD)
-
Cardiopulmonary Resuscitation (CPR)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.